Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00522717 · ClinicalTrials.gov registry record · NA
Enhancing Recovery After Cardiac Surgery
A NA study of Depression and Coronary Artery Disease, sponsored by University of California, Los Angeles.
- Completed
- Registry status
- NA
- Development phase
- 808
- Enrollment target
- 5
- Study locations
NCT00522717: Completed NA study of Depression and Coronary Artery Disease, sponsored by University of California, Los Angeles.
NCT00522717 is a NA study of Depression and Coronary Artery Disease that has completed, run by University of California, Los Angeles. The registered enrollment target is 808 participants, roughly in line with the 785-participant average among 679 other Depression trials with a reported enrollment target. The trial reports 5 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00522717, a NA study of Depression and Coronary Artery Disease, has completed, sponsored by University of California, Los Angeles.
- COMPLETED
- Registry status
- NA
- Development phase
- 808 participants
- Enrollment target
- 5
- Study locations
Study Summary
Patients recovering from coronary artery bypass graft (CABG) surgery have high rates of depression, and depression is associated with higher risk of complications and death. Recent discoveries show that depression involves changes in certain molecules in the blood, which are also involved in progressive coronary artery disease (CAD) and its complications. This study will evaluate the effects of cognitive behavioral therapy (CBT) as a treatment for depression on these biological markers among CABG patients.
Conditions Studied
Interventions
- BEHAVIORAL Cognitive Behavioral Therapy (CBT)
- BEHAVIORAL Usual Care
Study Locations (5)
California
- Long Beach Memorial Medical Center - Long Beach
- Cedars-Sinai Medical Center - Los Angeles
- Kaiser Permanente Medical Center - Sunset - Los Angeles
- Department of Veterans Affairs-Greater Los Angeles Healthcare System, West Los Angeles - Los Angeles
- University of California, Los Angeles School of Nursing - Los Angeles
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 808 participants |
| Start Date | 2005-07 |
| Est. Completion | 2010-05 |
| Phase | NA |
What the finished NCT00522717 record still lists
NCT00522717 is an interventional study that assigns participants to a tested intervention. The registered 808 participants enrollment target is mid-sized for trials with a published cap, roughly in line with the 785-participant average among 679 other Depression trials with a reported enrollment target.
The record links to 2 conditions, with Depression appearing as the primary indexed condition, and to 2 interventions - of which Cognitive Behavioral Therapy (CBT) is the first listed.
NCT00522717 lists 5 locations in 1 state (California).
Frequently Asked Questions
What is clinical trial NCT00522717 about?
NCT00522717 is a clinical study titled "Enhancing Recovery After Cardiac Surgery". Patients recovering from coronary artery bypass graft (CABG) surgery have high rates of depression, and depression is associated with higher risk of complications and death. Recent discoveries show that depression involves changes in certain molecules in the blood, which are also involved in progres...
What is the current status of trial NCT00522717?
This trial is currently completed. It is a NA study. The enrollment target is 808 participants. The study started on 2005-07. Estimated completion is 2010-05.
What conditions does trial NCT00522717 study?
This clinical trial studies the following conditions: Depression, Coronary Artery Disease.
What interventions are being tested in trial NCT00522717?
The interventions under investigation include: Cognitive Behavioral Therapy (CBT) (BEHAVIORAL), Usual Care (BEHAVIORAL).
Who is sponsoring clinical trial NCT00522717?
This trial is sponsored by University of California, Los Angeles, which has 897 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00522717 being conducted?
This trial has 5 study locations across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Depression
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00522717's enrollment target sits among peer trials
808 51st of 679 higher than 629 of 679 other Depression trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Depression trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Reaching Out to Distressed Medical Residents, Fellows and Faculty
RECRUITING · NA
-
IMPACT (IMproving Proactive Approaches for Cancer Survivors' Mental Health Treatment)
RECRUITING · NA
-
Cold and Heat Investigation to Lower Levels of Depression
RECRUITING · NA
-
Dosing rTMS for Depression Post-SCI
RECRUITING · NA
-
Exploring Virtual Reality Adventure Training Exergaming
RECRUITING · NA
-
Brief Interventions for Coping with Distress
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06529094 · 808 participants · NA
Implementing a Decision Support Tool to Prevent Community-Acquired Pressure Injury in Spinal Cord Injury (SCI) in the Spinal Cord Injury Clinic
- NCT05519085 · 810 participants · Phase 3
A Study to Evaluate Mezigdomide, Bortezomib and Dexamethasone (MEZIVd) Versus Pomalidomide, Bortezomib and Dexamethasone (PVd) in Participants With Relapsed or Refractory Multiple Myeloma (RRMM)
- NCT04613596 · 806 participants · Phase 2
Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7
- NCT06065098 · 806 participants · NA
Church-based Health Intervention to Eliminate Racial Inequalities in Cardiovascular Health
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia